These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evaluation of the National Eye Institute visual function questionnaire in Graves' ophthalmopathy. Bradley EA; Sloan JA; Novotny PJ; Garrity JA; Woog JJ; West SK Ophthalmology; 2006 Aug; 113(8):1450-4. PubMed ID: 16769116 [TBL] [Abstract][Full Text] [Related]
5. [Quality of life in Graves' ophthalmopathy (continuation of research)]. Warmuz-Stangierska I; Czarnywojtek A; Stangierski R; Sowiński J Przegl Lek; 2004; 61(8):857-9. PubMed ID: 15789917 [TBL] [Abstract][Full Text] [Related]
6. Mood and anxiety disorders in women with treated hyperthyroidism and ophthalmopathy caused by Graves' disease. Bunevicius R; Velickiene D; Prange AJ Gen Hosp Psychiatry; 2005; 27(2):133-9. PubMed ID: 15763125 [TBL] [Abstract][Full Text] [Related]
7. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease. de Bellis A; Perrino S; Coronella C; Sansone D; Ruocco G; Tirelli G; Di Martino S; Conte M; Bellastella G; Wall JR; Bellastella A; Bizzarro A Clin Endocrinol (Oxf); 2004 Jun; 60(6):694-8. PubMed ID: 15163332 [TBL] [Abstract][Full Text] [Related]
8. Effects of an expressive writing intervention on cancer-related distress in Danish breast cancer survivors - results from a nationwide randomized clinical trial. Jensen-Johansen MB; Christensen S; Valdimarsdottir H; Zakowski S; Jensen AB; Bovbjerg DH; Zachariae R Psychooncology; 2013 Jul; 22(7):1492-500. PubMed ID: 22991162 [TBL] [Abstract][Full Text] [Related]
9. [Mood of individuals with Graves-Basedow's disease and Hashimoto's disease]. Basińska MA; Merc M; Juraniec O Endokrynol Pol; 2009; 60(6):461-8. PubMed ID: 20041364 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids]. Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418 [TBL] [Abstract][Full Text] [Related]
11. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy. Prummel MF; Wiersinga WM; Mourits MP; Koornneef L; Berghout A; van der Gaag R Arch Intern Med; 1990 May; 150(5):1098-101. PubMed ID: 1691908 [TBL] [Abstract][Full Text] [Related]
12. Quality of life in patients with Graves' ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument. Gerding MN; Terwee CB; Dekker FW; Koornneef L; Prummel MF; Wiersinga WM Thyroid; 1997 Dec; 7(6):885-9. PubMed ID: 9459632 [TBL] [Abstract][Full Text] [Related]
13. 24 hours on-call and acute fatigue no longer worsen resident mood under the 80-hour work week regulations. Kiernan M; Civetta J; Bartus C; Walsh S Curr Surg; 2006; 63(3):237-41. PubMed ID: 16757379 [TBL] [Abstract][Full Text] [Related]
14. Effect of desvenlafaxine on mood and climacteric symptoms in menopausal women with moderate to severe vasomotor symptoms. Cheng RJ; Dupont C; Archer DF; Bao W; Racketa J; Constantine G; Pickar JH Climacteric; 2013 Feb; 16(1):17-27. PubMed ID: 22646219 [TBL] [Abstract][Full Text] [Related]
15. Assessment of quality of life and depression in Korean patients with Graves' ophthalmopathy. Lee H; Roh HS; Yoon JS; Lee SY Korean J Ophthalmol; 2010 Apr; 24(2):65-72. PubMed ID: 20379454 [TBL] [Abstract][Full Text] [Related]
16. A polymorphism of the 5' flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese. Kamizono S; Hiromatsu Y; Seki N; Bednarczuk T; Matsumoto H; Kimura A; Itoh K Clin Endocrinol (Oxf); 2000 Jun; 52(6):759-64. PubMed ID: 10848881 [TBL] [Abstract][Full Text] [Related]
17. [Inactive Graves' ophthalmopathy and self-esteem]. Magalhães CH; Pereira MD; Manso PG; Veiga DF; Novo NF; Ferreira LM Arq Bras Oftalmol; 2008; 71(2):215-20. PubMed ID: 18516421 [TBL] [Abstract][Full Text] [Related]
18. Plasma leptin concentrations in patients with Graves' disease with or without ophthalmopathy. Ozata M; Uckaya G; Bolu E; Corapcioglu D; Bingol N; Ozdemir IC Med Sci Monit; 2001; 7(4):696-700. PubMed ID: 11433197 [TBL] [Abstract][Full Text] [Related]
19. Serum antibodies to collagen XIII: a further good marker of active Graves' ophthalmopathy. De Bellis A; Sansone D; Coronella C; Conte M; Iorio S; Perrino S; Battaglia M; Bellastella G; Wall JR; Bellastella A; Bizzarro A Clin Endocrinol (Oxf); 2005 Jan; 62(1):24-9. PubMed ID: 15638866 [TBL] [Abstract][Full Text] [Related]
20. Quality of life in patients with Graves ophthalmopathy. Yeatts RP Trans Am Ophthalmol Soc; 2005; 103():368-411. PubMed ID: 17057811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]